Continuous Infusions vs Scheduled Bolus Infusions

NCT ID: NCT03230565

Last Updated: 2025-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

240 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Regional anesthetic techniques are an integral part to many anesthetic approaches, providing both intraoperative and postoperative anesthesia and analgesia. Regional anesthesia peripheral nerve blocks have been shown to reduce postoperative pain and improve measures such as opioid requirements and readiness for discharge. By using a catheter technique for continuous peripheral nerve blocks, analgesia can be extended well into post-operative days 2 and 3, further extending these benefits. Historically these catheters have implemented a continuous dosing regimen of local anesthetic, but increasingly there is evidence of improved analgesic outcomes without adverse effects by using a scheduled bolus dosing regimen. Many institutions have implemented this new protocol for catheter dosing. The beneficial effect of scheduled bolus dosing has not been studied in all blocks and all surgical procedures.

The study will consist of three independent arms, each designed to evaluate a different nerve block site: interscalene, adductor canal, and infraclavicular. A total of 60 patients will be enrolled in each arm.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Procedure, Unspecified Pain, Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Comparison of two groups: 1) Continuous infusion group 2) Bolus infusion group
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Investigators and participants will be masked to treatment group. Care providers will be necessarily unmasked.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Continuous Infusion

Local anesthetic medication (Ropivacaine 0.2%) is provided at a continuous basal rate.

Group Type ACTIVE_COMPARATOR

Ropivacaine

Intervention Type DRUG

Patient will be given a continuous infusion of local anesthetic.

Intermittent Bolus Infusion

Local anesthetic medication (Ropivacaine 0.2%) is provided in scheduled, intermittent boluses.

Group Type ACTIVE_COMPARATOR

Ropivacaine

Intervention Type DRUG

Patient will be given a scheduled intermittent bolus of local anesthetic.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ropivacaine

Patient will be given a continuous infusion of local anesthetic.

Intervention Type DRUG

Ropivacaine

Patient will be given a scheduled intermittent bolus of local anesthetic.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Continuous infusion Bolus Infusion

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients presenting for nerve block catheters for post-operative analgesia
* ASA physical status I, II, or III.

Exclusion Criteria

* Pregnancy
* Incarceration
* Age \<18
* BMI \>35
* Pre-operative opioid use \>30 mg morphine equivalents per day
* Inability to communicate with investigators by telephone
* Pre-existing neuropathy of the operative extremity.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jean-Louis Horn

Professor of Anesthesiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean Louis-Horn, MD

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University

Stanford, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aaron J Deng, BS

Role: CONTACT

408-914-5494

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Archana Verma

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

41434

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multimodal Pain Management Following Primary TKA
NCT02369523 TERMINATED EARLY_PHASE1
Continuous Serratus Anterior Blockade for Sternotomy
NCT04648774 ACTIVE_NOT_RECRUITING NA